ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, featuring promising enhancements across numerous professional medical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, extra trustworthy alternative for therapeutic